Hypoplastic Left Heart Syndrome | CHOP Research Institute

Hypoplastic Left Heart Syndrome

The Lynch Lab's primary focus is on the development and use of novel biomedical optical tools to study risk for neurologic injury in children with cardiac diseases.

Published on
Apr 28, 2023
Learn about the home renovations funded by CAPP+ to reduce asthma triggers and more in this week’s edition of In the News.

The purpose of this research study is to learn more about improving the treatment and outcomes for patients who have a diagnosis of a single ventricle, such as Hypoplastic Left Heart Syndrome (HLHS) or similar heart defects.

The purpose of this research study is to find out if stem cells from umbilical cord blood can strengthen the muscle of the right side of the heart for patients diagnosed with Hypolplastic Left Heart Syndrome who are scheduled to undergo the Stage II Glenn surgical procedure.

Conducting a group of dynamic research projects for families affected by hypoplastic left heart syndrome, including research involving the use of autologous stem cells (from the patient’s own body) derived from umbilical cord blood collected at birth.

Published on
Mar 29, 2018
This month's Research Heroes, Haley and Jax Readman, have a heart to heart about participating in single ventricle defect research at CHOP.
Published on
Feb 24, 2017
This week's In the News highlights remind us of one of our favorite quotes from Helen Keller: "Alone we can do so little; together we can do so much." Read on to see how researchers from Children's Hospital of Philadelphia are working with different groups who share the same vision and scientific goals to advance pediatric care.

Study Uses Brain